Evidence map›Paper›PMID 27789709›Full record

ArticleThe Journal of biological chemistry2016

Concerted Action of PGC-1-related Coactivator (PRC) and c-MYC in the Stress Response to Mitochondrial Dysfunction.

Natalie Gleyzer, Richard C Scarpulla

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. MYC-an emerging player in mitochondrial diseases.Frontiers in cell and developmental biology · 2023
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. NO control of mitochondrial function in normal and transformed cells.Biochimica et biophysica acta. Bioenergetics · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Natalie GleyzerFrom the Department of Cell and Molecular Biology, Northwestern Medical School, Chicago, Illinois 60611.
Richard C ScarpullaFrom the Department of Cell and Molecular Biology, Northwestern Medical School, Chicago, Illinois 60611 rsc248@northwestern.edu.
Northwestern University · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
TRANSCRIPTIONAL CONTROL BY NUCLEAR RESPIRATORY FACTORSR01GM032525 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SCARPULLA, RICHARD · 1985 to 2012
$4.6M
Nuclear Control of Respiratory Chain ExpressionR56GM032525 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SCARPULLA, RICHARD · 2007 to 2007
$478k
NCI NIH HHS P30 CA060553NIGMS NIH HHS R01 GM032525NIGMS NIH HHS R56 GM032525
6 · The paper itself

Abstract

PGC-1-related coactivator (PRC) has a dual function in growth-regulated mitochondrial biogenesis and as a sensor of metabolic stress. PRC induction by mitochondrial inhibitors, intracellular ROS, or topoisomerase I inhibition orchestrates an inflammatory program associated with the adaptation to cellular stress. Activation of this program is accompanied by the coordinate expression of c-MYC, which is linked kinetically to that of PRC in response to multiple stress inducers. Here, we show that the c-MYC inhibitor 10058-F4 blocks the induction of c-MYC, PRC, and representative PRC-dependent stress genes by the respiratory chain uncoupler, carbonyl cyanide m-chlorophenyl hydrazine (CCCP). This result, confirmed by the suppression of PRC induction by c-MYC siRNA silencing, demonstrates a requirement for c-MYC in orchestrating the stress program. PRC steady-state expression was markedly increased upon mutation of two GSK-3 serine phosphorylation sites within the carboxyl-terminal domain. The negative control of PRC expression by GSK-3 was consistent with the phosphor-inactivation of GSK-3β by CCCP and by the induction of PRC by the GSK-3 inhibitor AZD2858. Unlike PRC, which was induced post-translationally through increased protein half-life, c-MYC was induced predominantly at the mRNA level. Moreover, suppression of Akt activation by the Akt inhibitor MK-2206 blocked the CCCP induction of PRC, c-MYC, and representative PRC stress genes, demonstrating a requirement for Akt signaling. MK-2206 also inhibited the phosphor-inactivation of GSK-3β by CCCP, a result consistent with the ability of Akt to phosphorylate, and thereby suppress GSK-3 activity. Thus, PRC and c-MYC can act in concert through Akt-GSK-3 signaling to reprogram gene expression in response to mitochondrial stress.

Indexed as

Signal TransductionStress, PhysiologicalCarbonyl Cyanide m-Chlorophenyl HydrazoneCell Line, TumorGlycogen Synthase Kinase 3 betaHeterocyclic Compounds, 3-RingHumansMitochondriaPhosphorylationProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-mycPyrazinesSulfonamidesThiazolesTranscription Factors5-(4-ethylbenzylidene)-2-thioxothiazolidin-4-oneAZD2858Carbonyl Cyanide m-Chlorophenyl HydrazoneGlycogen Synthase Kinase 3 betaGSK3B protein, humanHeterocyclic Compounds, 3-RingMK 2206MYC protein, humanperoxisome-proliferator-activated receptor-gamma coactivator-1Proto-Oncogene Proteins c-aktProto-Oncogene Proteins c-mycPyrazinesSulfonamidesThiazolesTranscription Factorsgene regulationmetabolismmitochondriasignalingstress

Identifiers

PMID27789709
PMCPMC5207252
OpenAlexW2540787413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.